Posts From Janine

Janine

Janine

Janine is our editor for related stock market news. Andrew and Janine will be focusing on providing the latest trends and where the next hit could be

Tesla Rallies on Goldman Upgrade with Street-High Target

   Electric car manufacturer Tesla Inc (Nasdaq: TSLA) hogged the limelight yesterday following the rating upgrade by Mark Delaney, an analyst at Goldman Sachs, citing an expedited adoption of electric vehicles. Following the news of the rating upgrade, the

Read More

AstraZeneca to Launch Another Global Trial of COVID-19 Vaccine

   AstraZeneca PLC (Nasdaq: AZN) is contemplating another worldwide trial of its COVID-19 vaccine to reaffirm the 90% efficacy rate using a lower dosage, as per a report published by Bloomberg news. The British–Swedish multinational biopharmaceutical company and its

Read More

Nasdaq Buys Anti-Financial Fraud Firm Verafin for $2.75 Billion

   Exchange operator Nasdaq Inc (Nasdaq: NDAQ) stated on Thursday that it is acquiring Verafin, a software firm focused on identifying financial frauds, in an all-cash deal worth $2.75 billion. The agreement enables Nasdaq to widen its foothold in

Read More

Moderna to Publish COVID-19 Vaccine Results by End of November

  Pharmaceutical company Moderna Inc (Nasdaq: MRNA) has announced that it has adequate info from the late-stage trial of its potential COVID-19 vaccine to start a scheduled interim analysis. However, the company did not provide any precise date for publishing

Read More

Clorox Beats Q1 Estimates and Upwardly Revises FY 2021 View

   Household products maker Clorox Co (NYSE: CLX) reported fiscal 2021 first-quarter results that blew away Wall Street estimates as the company gained from the purchases by consumers who are confined to home because of the pandemic. The company

Read More

Intel Beats Q3 Estimates But Data Center Business Falters

  The stock of chipmaker Intel Corp (Nasdaq: INTC) was beaten on Friday after the company’s third-quarter earnings report indicated weakness in the data center business division. Nevertheless, the company’s top and bottom line surpassed the Street estimates. The company

Read More

HPE Upwardly Revises FY 2021 View Above Analysts’ Forecasts

  Hewlett Packard Enterprise Co (NYSE: HPE) upwardly revised its FY 2021 outlook, stating that the work at home scenario caused by the COVID-19 pandemic has increased the demand for its products and services. The upwardly revised FY 2021 earnings

Read More

Morgan Stanley Beats Estimates as Trading Division Excels

  The US-headquartered multinational investment bank Morgan Stanley (NYSE: MS) reported fiscal 2020 third-quarter profit that rose 26% on a y-o-y basis. Revenues grew 16% from last year as all business divisions performed well. Both earnings and revenues surpassed Wall

Read More

Bristol Myers to Buy Heart Drug Focused MyoKardia for $13bln

  The pharmaceutical company Bristol-Myers Squibb Co (NYSE: BMY) is acquiring biotechnology company MyoKardia Inc (Nasdaq: MYOK) in an all-cash deal worth $13.10 billion. Specifically, Bristol-Myers is paying $225 per share of MyoKardia. The acquisition will further reduce the dependence

Read More

Accenture Down as EPS and Q1 Outlook Disappoint Analysts

  Technology consulting firm Accenture PLC (NYSE: ACN) reported fiscal 2020 fourth-quarter earnings and revenues below analysts’ estimates. The company also issued a lower-than-anticipated Q1 and FY 2021 outlook as clients have tightened their purse strings due to the COVID-19

Read More